Checkmate Pharmaceuticals Overview

Checkmate Pharmaceuticals Operating Income

Operating Income for CMPI.

Quarterly Operating Income

$-15848000.00

↑ 11.76% YoY

As of Mar 31, 2022

Annual Operating Income (TTM)

$-63124000.00

↑ 45.91% YoY

Trailing 12 months ending Mar 31, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin